Reporter July 10 2015 Archive — Page 1 of 2

Assorted brightly colored capsules scattered on a white background.
July 15, 2015

Drug signaling networks

Vanderbilt investigators have developed a new algorithm to understand the networks of signaling molecules that control drug action.

Illustration of red blood cells and several white blood cells suspended in a red bloodstream.
July 13, 2015

Hhex on cancer

A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production.

Red heart-shaped object with three adhesive bandages crossed over its center on a white background.
July 10, 2015

Delivering cells for heart repair

A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair.

Abstract silhouette of a human head filled with a glowing tunnel of blue-white dots, surrounded by scattered white and blue jigsaw puzzle pieces.
July 9, 2015

Signals of schizophrenia

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.

July 9, 2015

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

Portrait of a smiling, gray-haired woman wearing glasses and a light-colored jacket outdoors.
July 9, 2015

Gates grant bolsters study of Tdap boosters in pregnant women

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.